Aspirin is a medication commonly used to reduce pain, fever, or inflammation. In this clinical trial, it is being studied for its effects on platelet aggregation in people with Type One Diabetes. Platelet aggregation is a process where blood cells called platelets clump together, which can lead to blood clots. The trial aims to understand how well aspirin works in preventing this clumping in diabetic patients, especially those with different levels of kidney damage, compared to healthy individuals.

Atherosclerotic cardiovascular disease – This disease involves the buildup of fatty deposits, known as plaques, in the walls of arteries. Over time, these plaques can harden and narrow the arteries, reducing blood flow. The progression of the disease can lead to the arteries becoming completely blocked. This blockage can result in reduced oxygen supply to vital organs. As the disease advances, it can cause complications such as chest pain or heart attacks. The condition can affect various arteries throughout the body, including those in the heart, brain, and limbs.

Type 1 diabetes – This is an autoimmune condition where the body’s immune system attacks and destroys insulin-producing cells in the pancreas. As a result, the body produces little or no insulin, a hormone necessary for glucose to enter cells and produce energy. The disease typically develops in childhood or adolescence but can occur at any age. Without insulin, blood sugar levels rise, leading to symptoms such as increased thirst, frequent urination, and fatigue. Over time, high blood sugar levels can cause damage to various organs and tissues. The progression of the disease requires careful management of blood sugar levels.

Diabetic kidney disease – This condition is a complication of diabetes that affects the kidneys. It occurs when high blood sugar levels damage the blood vessels in the kidneys, impairing their ability to filter waste from the blood. As the disease progresses, it can lead to the leakage of protein into the urine, a condition known as albuminuria. Over time, the kidneys may lose their function, leading to chronic kidney disease. The progression can eventually result in kidney failure if not managed properly. This condition requires monitoring and management to slow its progression.